| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7K | +0.0% |
| Gross Profit | $7K | +0.0% |
| R&D Expense | $2.4M | -21.4% |
| SG&A Expense | $10.9M | +373.7% |
| Operating Income | -$13.3M | -149.9% |
| Pre-tax Income | -$25.9M | -387.0% |
| Net Income | -$25.9M | -387.0% |
| EPS (Basic) | -$0.26 | -225.0% |
| EPS (Diluted) | -$0.26 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.4M | — |
| Accounts Receivable | $999 | -53.8% |
| Inventory | $24K | +7.5% |
| Current Assets | $3.9M | +1406.8% |
| Total Assets | $8.0M | +79.6% |
| Total Liabilities | $30.9M | +2933.0% |
| Stockholders' Equity | -$22.9M | -771.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | -281.3% |
| Investing Cash Flow | -$246K | +34.6% |
| Financing Cash Flow | $11.0M | +187.1% |
| -225.0% |